FIELD: medicine.
SUBSTANCE: invention relates to a compound of the formula (I), having antagonistic activity relatively to a calcium-sensitive receptor.
EFFECT: new compounds of the formula (I) are obtained, which can be used for the preparation of a drug for the prevention or treatment of heart failure or pulmonary hypertension by antagonization of a calcium-sensitive receptor.
9 cl, 1 dwg, 12 tbl, 21 ex
Title | Year | Author | Number |
---|---|---|---|
HETEROCYCLIC COMPOUND | 2018 |
|
RU2768473C2 |
SUBSTITUTED PYRAZOLOPYRIMIDINES AS GLUCOCEREBROSIDASE ACTIVATORS | 2011 |
|
RU2603637C2 |
SULFONAMIDE-CONTAINING BINDING SYSTEMS FOR MEDICINAL CONJUGATES | 2014 |
|
RU2729194C2 |
COMPOUNDS OF TETRAHYDROPYRASOLOPIRIMIDINE | 2013 |
|
RU2677291C2 |
NEW CONDENSED PYRROLE CARBOXYLIC ACID AMIDES: NOVEL CLASS OF LIGANDS OF BRAIN GABA-RECEPTORS | 1997 |
|
RU2167151C2 |
ANELLATED CARBAMOYL AZAHETEROCYCLES, METHODS FOR THEIR PREPARING (VARIANTS), PHARMACEUTICAL COMPOSITION, FOCUSED LIBRARY | 2004 |
|
RU2266906C1 |
ANTITUMOR EFFECT STRENGTHENING AGENT USING PYRAZOLO[3,4-d]PYRIMIDINE COMPOUND | 2018 |
|
RU2799006C2 |
NOVEL PYRAZOLO[3,4-D]PYRIMIDINE COMPOUND OR SALT THEREOF | 2016 |
|
RU2705579C2 |
METHOD FOR TREATMENT OF ALLERGY BY USING SUBSTITUTED PYRAZOLES | 2001 |
|
RU2259202C2 |
DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE | 2014 |
|
RU2662832C2 |
Authors
Dates
2022-06-03—Published
2018-04-26—Filed